Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing.

[1]  M. Josephson,et al.  Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease: An Analysis of Patients Enrolled in the Multicenter Unsustained Tachycardia Trial , 2002, Circulation.

[2]  W. Kapoor.  Current Evaluation and Management of Syncope , 2002, Circulation.

[3]  M. Massarotti,et al.  Homocysteine and vascular diseases. , 2002, Circulation.

[4]  M. Horrigan,et al.  Delayed neurally mediated syncope after inferior wall acute myocardial infarction. , 2002, The American journal of cardiology.

[5]  Douglas L Packer,et al.  Effect of Implantable Defibrillators on Arrhythmic Events and Mortality in the Multicenter Unsustained Tachycardia Trial , 2002, Circulation.

[6]  A. Skanes,et al.  Comparison of patients with syncope with left ventricular dysfunction and negative electrophysiologic testing to cardiac arrest survivors and patients with syncope and preserved left ventricular function and impact of an implantable defibrillator. , 2002, The American journal of cardiology.

[7]  R. García-Civera,et al.  Mechanism of Syncope in Patients With Heart Disease and Negative Electrophysiologic Test , 2002, Circulation.

[8]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[9]  W. Grimm,et al.  Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. , 2002, Journal of the American College of Cardiology.

[10]  Wojciech Zareba,et al.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.

[11]  W. Shen,et al.  Role of Programmed Ventricular Stimulation and Implantable Cardioverter Defibrillators in Patients with Idiopathic Dilated Cardiomyopathy and Syncope , 2001, Pacing and clinical electrophysiology : PACE.

[12]  S. Markowitz,et al.  Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope. , 2001, Journal of the American College of Cardiology.

[13]  M. Brignole,et al.  Diagnostic value of history in patients with syncope with or without heart disease. , 2001, Journal of the American College of Cardiology.

[14]  A. Hallstrom,et al.  Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy? Evaluation of the Canadian implantable defibrillator study implantable cardioverter defibrillatory efficacy score in the antiarrhythmics versus implantable d , 2001, American heart journal.

[15]  E. Prystowsky,et al.  Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia. , 1999, Journal of the American College of Cardiology.

[16]  S. Markowitz,et al.  Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. , 1999, Journal of the American College of Cardiology.

[17]  J. Brugada,et al.  Arrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator: analysis according to the clinical presentation. , 1999, Journal of the American College of Cardiology.

[18]  Joseph Me.  Should ICDs be implanted in all patients with dilated cardiomyopathy and unexplained syncope , 1999 .

[19]  F. Morady,et al.  Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. , 1999, Journal of the American College of Cardiology.

[20]  P. J. Wang,et al.  Long-term outcome of patients with syncope associated with coronary artery disease and a nondiagnostic electrophysiologic evaluation. , 1999, The American journal of cardiology.

[21]  J. Mason,et al.  Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators. , 1999, American heart journal.

[22]  M. Josephson.  Should ICDs be implanted in all patients with dilated cardiomyopathy and unexplained syncope? , 1999, Journal of the American College of Cardiology.

[23]  W. Grimm,et al.  Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. , 1998, Journal of the American College of Cardiology.

[24]  R. Sheldon,et al.  Isoproterenol tilt-table testing in patients with syncope and structural heart disease. , 1996, The American journal of cardiology.

[25]  B. Brembilla-Perrot,et al.  Significance and prevalence of inducible atrial tachyarrhythmias in patients undergoing electrophysiologic study for presyncope or syncope. , 1996, International journal of cardiology.

[26]  S. Briançon,et al.  Programmed ventricular stimulation in survivors of acute myocardial infarction: long-term follow-up. , 1995, International journal of cardiology.

[27]  J. Bourke,et al.  Does the induction of ventricular flutter or fibrillation at electrophysiologic testing after myocardial infarction have any prognostic significance? , 1995, The American journal of cardiology.

[28]  W. Stevenson,et al.  Prognosis after syncope: impact of left ventricular function. , 1993, American heart journal.

[29]  W. Stevenson,et al.  Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. , 1993, Journal of the American College of Cardiology.

[30]  B. Brembilla-Perrot,et al.  Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. , 1991, American heart journal.

[31]  P. Sax,et al.  Clinical, echocardiographic and Doppler correlates of clinical instability with onset of atrial fibrillation. , 1990, The American journal of cardiology.

[32]  D. Waters,et al.  Programmed ventricular stimulation in survivors of an acute myocardial infarction. , 1985, Circulation.

[33]  M. Mazuz,et al.  Significance of inducible tachycardia in patients with syncope of unknown origin: a long-term follow-up. , 1985, Journal of the American College of Cardiology.

[34]  F. Morady,et al.  Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing. , 1983, Journal of the American College of Cardiology.